Gene Therapy Market by Vector Type (Viral Vector and Non-Viral Vector), by Therapy (In Vivo Therapy and Ex Vivo Therapy), by Indication (Oncology Diseases, Cardiovascular Diseases, Orthopedic Diseases, Ophthalmology Diseases, Central Nervous System Disorders, Infectious Diseases, and Others), by Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Receptors, and Others), by Application (Oncology, Dermatology, Musculoskeletal, and Others), by End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Others) – Global Opportunity Analysis and Industry Forecast 2024-2030
Please provide your company email address for a faster response
This website uses cookies to ensure you get the best experience on our website. Learn more
✖